Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
The American Journal of Drug and Alcohol Abuse|February 9, 2018
Open-label pilot study of injectable naltrexone for cannabis dependenceDaniel P Notzon, Meredith A Kelly, C Jean Choi, et al.Drug and Alcohol Dependence|January 8, 2021
Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trialFrances R Levin, John J Mariani, Martina Pavlicova, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthElizabeth Muñoz, Lourdes S Romañach Álvarez, Jean Choi, et al.The American Journal of Psychiatry|October 20, 2018
A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use DisorderMaria A Sullivan, Adam Bisaga, Martina Pavlicova, et al.Journal of Attention Disorders|July 25, 2024
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled TrialFrances R Levin, John J Mariani, Martina Pavlicova, et al.AIDS (London, England)|April 15, 2020
Psychiatric trajectories across adolescence in perinatally HIV-exposed youth: the role of HIV infection and associations with viral loadNadia Nguyen, C Jean Choi, Reuben Robbins, et al.Development and Psychopathology|August 3, 2018
Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromisedHanna C Gustafsson, Sherryl H Goodman, Tianshu Feng, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 7, 2021
Hearing Rehabilitative Treatment for Older Adults With Comorbid Hearing Loss and Depression: Effects on Depressive Symptoms and Executive FunctionKatharine Brewster, C Jean Choi, Xiaofu He, et al.Drug and Alcohol Dependence Reports|February 27, 2023
Intranasal oxytocin may improve odds of abstinence in cocaine-dependent patients: results from a preliminary studyWilfrid Noël Raby, Matthew Heller, Demetrios Milliaressis, et al.Journal of Substance Use|July 18, 2024
Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use DisorderChristina A Brezing, Mohammad Sibai, C Jean Choi, et al.Pageof 8